New treatment option for Femoro Acetabular Impingement
Official title Ultrasound-guided Needle Percutaneous Electrolysis With Therapeutic Exercise in Femoroacetabular Impingement Syndrome
ClinicalTrials.gov ID: NCT07548034
What this study is testing
- What it's testing
- Hip pain in the front of the hip is common and can make daily activities and sports difficult. One frequent cause is femoroacetabular impingement, also known as hip impingement.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55
You may be able to join if
- Anterior hip pain (inguinal region) lasting more than 3 months
- Numeric Rating Scale (NRS) pain score ≥ 4/10 during at least one provocative test
- Positive result in at least one of the following clinical tests: Straight Leg Raise (SLR), Flexion-Adduction-Internal Rotation (FADIR), or...
- Ultrasound findings compatible with pseudofibrotic tissue near the iliopsoas tendon at the anterosuperior acetabular recess
- Age between 18 and 55 years
You likely can't join if
- Previous hip surgery
- Moderate or severe hip osteoarthritis (diagnosed radiographically)
- Neurological pathology affecting the lower limb
- Dominant lumbar spine pathology
- Active rheumatic or systemic inflammatory diseases
- Any contraindication to percutaneous electrolysis
See the full eligibility criteria
- Anterior hip pain (inguinal region) lasting more than 3 months
- Numeric Rating Scale (NRS) pain score ≥ 4/10 during at least one provocative test
- Positive result in at least one of the following clinical tests: Straight Leg Raise (SLR), Flexion-Adduction-Internal Rotation (FADIR), or Hip-External Rotation-Flexion-Ceiling (HEC)
- Ultrasound findings compatible with pseudofibrotic tissue near the iliopsoas tendon at the anterosuperior acetabular recess
- Age between 18 and 55 years
- Able to provide written informed consent
- Previous hip surgery
- Moderate or severe hip osteoarthritis (diagnosed radiographically)
- Neurological pathology affecting the lower limb
- Dominant lumbar spine pathology
- Active rheumatic or systemic inflammatory diseases
- Any contraindication to percutaneous electrolysis
- Belonephobia
The study team makes the final eligibility decision.
Where it's taking place
- Alcobendas, Madrid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alcobendas, Madrid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.